MedTech Business Review: Specials Magazine

A transcatheter route may be shared across procedures, but the anatomy is different in each valve position. Aortic stenosis, pulmonary regurgitation, mitral regurgitation and tricuspid regurgitation each place different demands on a replacement valve. Frame geometry, anchoring, sealing, coronary access and deployment behavior must also account for the anatomy. Venus Medtech [HKG: 2500] has built its structural-heart portfolio around those differences. Founded in 2009, the company develops transcatheter solutions across all four heart valves. It began with transcatheter aortic valve replacement (TAVR) and has since expanded into transcatheter pulmonary valve replacement (TPVR), as well as investigational transcatheter replacement programs for the mitral and tricuspid valves. The common thread is not one valve design repeated across indications. It is an approach that starts with the anatomical and procedural demands of each valve, then applies a different device design to address them. Control at the Aortic Valve VenusA-Valve established the TAVR pattern in the aortic space. Approved in China in 2017, it became the country’s first approved TAVR system. Its self-expanding frame was designed with enhanced radial force, which was intended to address the high incidence of bicuspid anatomy and heavy calcification among Chinese patients.

Technology alone does not change dentistry. Knowing how to use it does. At MV Dental Laboratory, every new digital tool, software platform and workflow is evaluated with one question in mind: will it help clinicians work more efficiently and deliver a better outcome for patients? That mindset has shaped a laboratory that is constantly testing, refining and adopting new ways of working rather than settling for yesterday's best practice. As a specialist Crown and Bridge laboratory with particular expertise in All-on-X, implant crowns and implant bridges, MV Dental Laboratory has built its reputation by combining advanced digital workflows with deep technical knowledge and close collaboration with clinicians across Australia. The result is a restorative process that saves valuable clinical time, reduces chairside adjustments and delivers predictable, natural-looking outcomes for patients. While many laboratories focus on investing in new equipment, owner Marc Meura believes the real competitive advantage lies elsewhere..